ArticleInternational ophthalmology2022

Intravitreal bevacizumab to treat retinopathy of prematurity in 865 eyes: a study to determine predictors of primary treatment failure and recurrence.

Kaveh Fadakar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.